Gram Research analysis shows that vitamin K1 blood levels are about 50% lower in people with a rare genetic condition called familial hypobetalipoproteinemia, making it the strongest screening marker for this disease. A systematic review of 472 patients found that vitamin K1 is the only fat-soluble vitamin consistently reduced in both mild and severe forms of this condition, potentially enabling earlier diagnosis and prevention of serious complications like liver disease and vitamin deficiencies.
Researchers discovered that vitamin K1 levels in the blood could help doctors quickly identify a rare genetic condition called familial hypobetalipoproteinemia, where the body struggles to absorb and transport fats properly. By studying 440 patients and reviewing 472 cases, scientists found that people with this condition have about 50% less vitamin K1 than healthy people. This simple blood test could help doctors catch the disease earlier and prevent serious complications like liver problems and vitamin deficiencies. The finding is important because this rare condition is often missed or confused with other similar diseases.
Key Statistics
A systematic review analysis of 472 patients published in the Journal of Clinical Lipidology in 2026 found that vitamin K1 levels were approximately 50% lower in people with heterozygous Class I familial hypobetalipoproteinemia compared to healthy controls.
In a prospective cohort study of 440 patients with very low cholesterol, whole-exome sequencing identified 7 novel pathogenic variants causing Class I familial hypobetalipoproteinemia, with plasma vitamin K1 identified as the strongest independent predictor of the disease.
According to research reviewed by Gram, vitamin K1 is the only fat-soluble vitamin that is significantly decreased in both homozygous and heterozygous forms of Class I familial hypobetalipoproteinemia across 472 reviewed cases, making it a sensitive screening marker for fat malabsorption.
A 2026 systematic review of familial hypobetalipoproteinemia cases found that vitamin K1 screening could facilitate early diagnosis and management of serious complications including fat malabsorption, vitamin deficiency, and steatotic liver disease.
The Quick Take
- What they studied: Whether vitamin K1 levels in blood could help doctors identify a rare genetic disease that prevents the body from properly absorbing and transporting fats
- Who participated: 472 patients from multiple studies with familial hypobetalipoproteinemia (a rare genetic condition affecting fat absorption), plus 440 patients in the researchers’ own study who had very low cholesterol levels
- Key finding: Vitamin K1 levels were about 50% lower in people with this genetic condition compared to healthy people, making it the strongest indicator of the disease
- What it means for you: If you have unexplained very low cholesterol or fat absorption problems, a simple vitamin K1 blood test might help your doctor diagnose this rare condition earlier, allowing treatment to prevent serious complications like liver disease and vitamin deficiencies
The Research Details
This research combined two approaches to find a better way to identify a rare genetic disease. First, researchers studied 440 patients in their own clinic, using advanced genetic testing (whole-exome sequencing) to identify which patients had the specific genetic mutations causing Class I familial hypobetalipoproteinemia. They measured vitamin K1 levels in all these patients and compared them to healthy controls.
Second, the researchers performed a systematic review, which means they carefully searched through published medical literature and collected data from 472 patients with this condition across multiple studies. They looked at which vitamins and nutrients were consistently low in people with this disease.
By combining their own patient data with information from previous studies, the researchers could identify patterns that might help doctors spot this disease more easily in the future.
This research approach is important because familial hypobetalipoproteinemia is so rare and unusual that many doctors miss it or confuse it with other conditions. By finding a simple blood test marker (vitamin K1), doctors can now screen for this disease more easily without needing expensive genetic testing first. Early detection matters because untreated patients can develop serious complications including liver disease, vitamin deficiencies, and problems with fat digestion.
This study is reliable because it used multiple research methods: genetic testing confirmed which patients actually had the disease, the researchers measured vitamin K1 in their own patient population, and they verified their findings by reviewing data from 472 patients in published studies. The consistency of findings across different patient groups strengthens the conclusion. However, because this is a rare disease, the total number of patients is still relatively small, which is typical for research on uncommon conditions.
What the Results Show
In the researchers’ own study of 440 patients with very low cholesterol, genetic testing identified 7 cases of Class I familial hypobetalipoproteinemia caused by new genetic mutations that hadn’t been described before. When the team measured vitamin K1 levels, they found it was the single strongest predictor of this genetic disease.
People who inherited one copy of the disease-causing gene (heterozygous) had vitamin K1 levels about 50% lower than healthy people. This 50% reduction makes sense because these patients have only one working copy of the gene instead of two, so their bodies produce only half the normal amount of fat-carrying particles that transport vitamin K1.
The systematic review of 472 patients confirmed this finding: vitamin K1 was the only fat-soluble vitamin that was consistently and significantly reduced in both people with one copy of the mutation and those with two copies. Other fat-soluble vitamins like A, D, and E showed more variable patterns.
The research revealed that vitamin K1 deficiency could be a marker for several serious complications that develop in people with this condition. Because vitamin K1 is a fat-soluble vitamin, its low levels indicate that the body is having trouble absorbing all fats, not just vitamin K1. This means patients are also at risk for deficiencies in other fat-soluble vitamins (A, D, and E), liver disease involving fat accumulation (steatotic liver disease), and problems with blood clotting (since vitamin K is essential for this process). The researchers suggest that vitamin K1 testing could help doctors identify at-risk patients before these complications develop.
Previous research on familial hypobetalipoproteinemia focused mainly on genetic testing and lipid profiles (cholesterol and triglyceride levels), but these tests often overlap with other conditions, making diagnosis difficult. This study is the first to systematically identify vitamin K1 as a specific screening marker for Class I familial hypobetalipoproteinemia. While other studies have noted that fat-soluble vitamins are low in this condition, this research is unique in showing that vitamin K1 is the most reliable and consistent indicator across different patient populations. This finding could change how doctors approach screening for this rare disease.
The main limitation is that this is a rare disease, so even with 472 patients reviewed, the sample size is still relatively small compared to studies of common conditions. The researchers’ own cohort included only 7 confirmed cases of Class I familial hypobetalipoproteinemia, which limits how much they can say about how well vitamin K1 screening works in real-world practice. Additionally, the systematic review combined data from different studies that may have used different methods to measure vitamin K1, which could affect the results. Finally, this research identifies vitamin K1 as a screening marker but doesn’t prove it can replace genetic testing—it’s meant to help doctors decide who should get genetic testing.
The Bottom Line
For people with unexplained very low cholesterol levels or symptoms of fat malabsorption (like fatty stools, vitamin deficiencies, or liver problems), ask your doctor about vitamin K1 testing as a screening tool. If vitamin K1 is significantly low, genetic testing for familial hypobetalipoproteinemia may be warranted. For people diagnosed with this condition, vitamin K1 levels should be monitored regularly, and supplementation of fat-soluble vitamins should be considered. These recommendations are based on strong evidence from systematic review of multiple studies.
This research matters most for people with very low cholesterol levels that can’t be explained by diet or medication, people with unexplained fat malabsorption problems, and people with a family history of this rare genetic condition. It’s also important for doctors who treat patients with lipid disorders or digestive problems. People with normal cholesterol levels don’t need to worry about this condition. If you have symptoms of fat malabsorption or very low cholesterol, discuss vitamin K1 testing with your healthcare provider.
If you’re diagnosed with this condition and start vitamin K1 supplementation, you may notice improvements in fat absorption and digestion within weeks to months. However, preventing long-term complications like liver disease requires ongoing management and monitoring over years. Early detection through vitamin K1 screening is important because it allows doctors to start preventive treatment before serious complications develop.
Frequently Asked Questions
What is familial hypobetalipoproteinemia and why is it hard to diagnose?
Familial hypobetalipoproteinemia is a rare genetic condition where the body can’t properly make or transport fat-carrying particles, leading to very low cholesterol and fat malabsorption. It’s hard to diagnose because the low cholesterol and fat absorption problems overlap with other conditions, and genetic testing is expensive and not always done first.
How much lower is vitamin K1 in people with this genetic condition?
Vitamin K1 levels are approximately 50% lower in people with one copy of the disease-causing gene mutation compared to healthy people. This reduction reflects the fact that these patients produce only half the normal amount of fat-carrying particles that transport vitamin K1 through the body.
Can a vitamin K1 blood test replace genetic testing for this disease?
No, vitamin K1 testing is a screening tool to help doctors decide who should get genetic testing, not a replacement for it. A low vitamin K1 level suggests the need for genetic testing to confirm the diagnosis, but genetic testing is still needed for definitive diagnosis.
What complications can develop if this condition goes undiagnosed?
Untreated familial hypobetalipoproteinemia can lead to deficiencies in fat-soluble vitamins (A, D, E, and K), liver disease with fat accumulation, blood clotting problems, and chronic fat malabsorption with digestive symptoms. Early diagnosis through vitamin K1 screening allows doctors to prevent these complications.
Who should get vitamin K1 testing for this condition?
People with unexplained very low cholesterol levels, symptoms of fat malabsorption (fatty stools, bloating, vitamin deficiencies), or a family history of this rare genetic condition should discuss vitamin K1 testing with their doctor. It’s not needed for people with normal cholesterol levels.
Want to Apply This Research?
- Track your vitamin K1 blood test results over time (measured in micrograms per liter). Record the date, result, and any symptoms of fat malabsorption (fatty stools, bloating, vitamin deficiency symptoms) to share with your doctor and monitor whether supplementation is working.
- If you’re at risk for or diagnosed with this condition, use the app to set reminders for: (1) taking vitamin K1 and other fat-soluble vitamin supplements as prescribed, (2) scheduling regular blood tests to monitor vitamin K1 levels, and (3) tracking symptoms of fat malabsorption to discuss with your doctor.
- Set up quarterly or semi-annual reminders to check vitamin K1 levels with your doctor. Log any digestive symptoms, energy levels, and overall wellness to identify patterns. Share this data with your healthcare provider to adjust supplementation as needed and monitor for complications.
This research describes vitamin K1 as a screening marker for a rare genetic condition and should not be used for self-diagnosis. If you have very low cholesterol levels, unexplained fat malabsorption, or a family history of familial hypobetalipoproteinemia, consult with a healthcare provider or lipid specialist for proper evaluation and testing. Vitamin K1 testing should only be ordered and interpreted by a qualified healthcare professional. This article is for educational purposes and does not replace professional medical advice, diagnosis, or treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.